NAUT
Nautilus Biotechnology, Inc.
1.96$
+24.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -7.7% | -5.1% | +206.5% | +2.9% | +3.7% | +7.1% | +27.1% | +21.3% | +6.7% | +5.0% | +0.1% | +0.4% | +0.9% | +294.1% | -74.4% | +0.5% | -0.9% | -1.9% | -7.1% | -176.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +11.4% | +20.6% | +11.5% | +30.7% | +25.7% | +31.0% | +20.9% | -2.6% | -8.6% | +11.6% | -3.4% | +13.5% | +9.7% | -0.1% | +3.6% | +4.2% | -3.9% | -1.3% | -7.9% | +6.3% | -9.9% | -7.6% | +13.7% | -14.2% | +2.6% | – | |
| – | -99.9% | -42.6% | +101.5% | +99.8% | +48.4% | +23.1% | +9.4% | +100.8% | +151.2% | +20.5% | +46.5% | +9.5% | -8.1% | +4.0% | -5.5% | +7.5% | +6.9% | -1.1% | -0.4% | +6.4% | +15.2% | -3.7% | -18.4% | +5.1% | +2.1% | -8.3% | -12.5% | -0.3% | +9.7% | -1.4% | – | |
| – | -99.9% | -42.6% | +101.5% | +99.8% | +744.0% | +13.4% | +18.4% | +27.3% | +64.2% | +23.5% | +37.5% | +15.8% | -8.1% | -3.8% | +8.0% | -2.8% | +9.8% | +4.2% | -0.2% | +4.8% | +8.7% | -4.1% | -8.9% | -22.1% | +38.3% | -9.3% | -9.5% | -10.6% | +5.9% | +16.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +202.3% | +141.3% | +52.8% | +7.2% | +4.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.9% | +19.3% | -28.0% | -37.5% | -861.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +8.7% | -17.0% | -7.5% | -148.4% | – | – | – | – | – | -335.3% | – | -142.7% | – | – | – | -207.2% | – | – | -194.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.9% | +19.3% | -28.0% | -37.5% | -861.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.9% | +19.3% | -28.0% | -37.5% | -836.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.